Characterization of CD22 expression in acute lymphoblastic leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|6|964-969

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.6, 2015-06, pp. : 964-969

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD56-Positive Acute Lymphoblastic Leukemia

By  

Acta Haematologica, Vol. 114, Iss. 3, 2005-10 ,pp. : 160-163

Karger

Access to resources Recommend Favorite

Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 371-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 7, 2015-07 ,pp. : 1144-1148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Higher Expression of the Novel Gene Upregulated Gene 4 in Two Acute Lymphoblastic Leukemia Patients with Poor Prednisolone Response

By  

Acta Haematologica, Vol. 128, Iss. 2, 2012-06 ,pp. : 73-76

Karger

Access to resources Recommend Favorite

Individualized therapy for childhood acute lymphoblastic leukemia

By Raetz Elizabeth A   Bhojwani Deepa   Min Dong-Joon   Carroll William L  

Personalized Medicine, Vol. 2, Iss. 4, 2005-11 ,pp. : 349-361

Future Medicine

Access to resources Recommend Favorite